Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2015-05-27 Tx date 2015-05-26 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Lonner, Anders
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$674,398
+2,866 vol $235.31 each |
28,564 | |
Filed 2015-05-27 Tx date 2015-05-26 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Lonner, Anders
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-65,886.80
-280 vol $235.31 each |
28,284 | |
Filed 2015-05-27 Tx date 2014-05-20 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Lonner, Anders
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-05-27 Tx date 2014-05-23 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Lonner, Anders
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$374,958
+2,866 vol $130.83 each |
2,866 | |
Filed 2015-05-27 Tx date 2015-05-22 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Lonner, Anders
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$374,864
+1,607 vol $233.27 each |
4,473 | |
Filed 2015-05-27 Tx date 2015-05-26 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Lonner, Anders
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-674,398.46
-2,866 vol $235.31 each |
1,607 |